319 related articles for article (PubMed ID: 25184385)
1. CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.
Korthuis PM; Berger G; Bakker B; Rozenveld-Geugien M; Jaques J; de Haan G; Schuringa JJ; Vellenga E; Schepers H
Leukemia; 2015 Mar; 29(3):625-35. PubMed ID: 25184385
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells.
Mattes K; Geugien M; Korthuis PM; Brouwers-Vos AZ; Fehrmann RSN; Todorova TI; Steidl U; Vellenga E; Schepers H
Exp Hematol; 2019 May; 73():38-49.e7. PubMed ID: 30986495
[TBL] [Abstract][Full Text] [Related]
3. CITED2 affects leukemic cell survival by interfering with p53 activation.
Mattes K; Berger G; Geugien M; Vellenga E; Schepers H
Cell Death Dis; 2017 Oct; 8(10):e3132. PubMed ID: 29072699
[TBL] [Abstract][Full Text] [Related]
4. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
Steidl U; Rosenbauer F; Verhaak RG; Gu X; Ebralidze A; Otu HH; Klippel S; Steidl C; Bruns I; Costa DB; Wagner K; Aivado M; Kobbe G; Valk PJ; Passegué E; Libermann TA; Delwel R; Tenen DG
Nat Genet; 2006 Nov; 38(11):1269-77. PubMed ID: 17041602
[TBL] [Abstract][Full Text] [Related]
5. Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.
Chesnais V; Arcangeli ML; Delette C; Rousseau A; Guermouche H; Lefevre C; Bondu S; Diop M; Cheok M; Chapuis N; Legros L; Raynaud S; Willems L; Bouscary D; Lauret E; Bernard OA; Kosmider O; Pflumio F; Fontenay M
Blood; 2017 Jan; 129(4):484-496. PubMed ID: 27856460
[TBL] [Abstract][Full Text] [Related]
6. A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network.
Anguita E; Gupta R; Olariu V; Valk PJ; Peterson C; Delwel R; Enver T
Dev Biol; 2016 Mar; 411(2):277-286. PubMed ID: 26851695
[TBL] [Abstract][Full Text] [Related]
7. Cited2 is an essential regulator of adult hematopoietic stem cells.
Kranc KR; Schepers H; Rodrigues NP; Bamforth S; Villadsen E; Ferry H; Bouriez-Jones T; Sigvardsson M; Bhattacharya S; Jacobsen SE; Enver T
Cell Stem Cell; 2009 Dec; 5(6):659-65. PubMed ID: 19951693
[TBL] [Abstract][Full Text] [Related]
8. CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation.
Lawson H; van de Lagemaat LN; Barile M; Tavosanis A; Durko J; Villacreces A; Bellani A; Mapperley C; Georges E; Martins-Costa C; Sepulveda C; Allen L; Campos J; Campbell KJ; O'Carroll D; Göttgens B; Cory S; Rodrigues NP; Guitart AV; Kranc KR
Stem Cell Reports; 2021 Nov; 16(11):2784-2797. PubMed ID: 34715054
[TBL] [Abstract][Full Text] [Related]
9. Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis.
Rizo A; Olthof S; Han L; Vellenga E; de Haan G; Schuringa JJ
Blood; 2009 Aug; 114(8):1498-505. PubMed ID: 19556423
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
11. Cited2 is required for normal hematopoiesis in the murine fetal liver.
Chen Y; Haviernik P; Bunting KD; Yang YC
Blood; 2007 Oct; 110(8):2889-98. PubMed ID: 17644732
[TBL] [Abstract][Full Text] [Related]
12. CITED2 functions as a molecular switch of cytokine-induced proliferation and quiescence.
Chou YT; Hsieh CH; Chiou SH; Hsu CF; Kao YR; Lee CC; Chung CH; Wang YH; Hsu HS; Pang ST; Shieh YS; Wu CW
Cell Death Differ; 2012 Dec; 19(12):2015-28. PubMed ID: 22814619
[TBL] [Abstract][Full Text] [Related]
13. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
[TBL] [Abstract][Full Text] [Related]
14. The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells.
Staber PB; Zhang P; Ye M; Welner RS; Levantini E; Di Ruscio A; Ebralidze AK; Bach C; Zhang H; Zhang J; Vanura K; Delwel R; Yang H; Huang G; Tenen DG
Blood; 2014 Oct; 124(15):2391-9. PubMed ID: 25185713
[TBL] [Abstract][Full Text] [Related]
15. In vitro expansion of CD34(+)CD38(-) cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia.
Sakashita K; Kato I; Daifu T; Saida S; Hiramatsu H; Nishinaka Y; Ebihara Y; Ma F; Matsuda K; Saito S; Hirabayashi K; Kurata T; Uyen LT; Nakazawa Y; Tsuji K; Heike T; Nakahata T; Koike K
Leukemia; 2015 Mar; 29(3):606-14. PubMed ID: 25102944
[TBL] [Abstract][Full Text] [Related]
16. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
[TBL] [Abstract][Full Text] [Related]
17. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.
Diffner E; Beck D; Gudgin E; Thoms JA; Knezevic K; Pridans C; Foster S; Goode D; Lim WK; Boelen L; Metzeler KH; Micklem G; Bohlander SK; Buske C; Burnett A; Ottersbach K; Vassiliou GS; Olivier J; Wong JW; Göttgens B; Huntly BJ; Pimanda JE
Blood; 2013 Mar; 121(12):2289-300. PubMed ID: 23327922
[TBL] [Abstract][Full Text] [Related]
18. IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo.
Yang J; Ikezoe T; Nishioka C; Nobumoto A; Yokoyama A
Int J Cancer; 2013 Oct; 133(8):1967-81. PubMed ID: 23564444
[TBL] [Abstract][Full Text] [Related]
19. The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell.
Shima T; Miyamoto T; Kikushige Y; Yuda J; Tochigi T; Yoshimoto G; Kato K; Takenaka K; Iwasaki H; Mizuno S; Goto N; Akashi K
Exp Hematol; 2014 Nov; 42(11):955-65.e1-5. PubMed ID: 25101977
[TBL] [Abstract][Full Text] [Related]
20. The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1.
Jenal M; Batliner J; Reddy VA; Haferlach T; Tobler A; Fey MF; Torbett BE; Tschan MP
Leukemia; 2010 May; 24(5):1073-6. PubMed ID: 20200559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
